190 related articles for article (PubMed ID: 25149661)
1. Adoption of hypofractionated whole-breast irradiation for early-stage breast cancer: a National Cancer Data Base analysis.
Wang EH; Mougalian SS; Soulos PR; Rutter CE; Evans SB; Haffty BG; Gross CP; Yu JB
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):993-1000. PubMed ID: 25149661
[TBL] [Abstract][Full Text] [Related]
2. Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials.
Jagsi R; Falchook AD; Hendrix LH; Curry H; Chen RC
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1001-9. PubMed ID: 25539365
[TBL] [Abstract][Full Text] [Related]
3. Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis.
Diwanji TP; Molitoris JK; Chhabra AM; Snider JW; Bentzen SM; Tkaczuk KH; Rosenblatt PY; Kesmodel SB; Bellavance EC; Cohen RJ; Cheston SB; Nichols EM; Feigenberg SJ
Breast Cancer Res Treat; 2017 Sep; 165(2):445-453. PubMed ID: 28639030
[TBL] [Abstract][Full Text] [Related]
4. Adoption of intensity modulated radiation therapy for early-stage breast cancer from 2004 through 2011.
Wang EH; Mougalian SS; Soulos PR; Smith BD; Haffty BG; Gross CP; Yu JB
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):303-11. PubMed ID: 25442334
[TBL] [Abstract][Full Text] [Related]
5. Choosing wisely? Patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of Michigan.
Jagsi R; Griffith KA; Heimburger D; Walker EM; Grills IS; Boike T; Feng M; Moran JM; Hayman J; Pierce LJ;
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1010-6. PubMed ID: 25539366
[TBL] [Abstract][Full Text] [Related]
6. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
[TBL] [Abstract][Full Text] [Related]
7. Clinical Pathways: A Catalyst for the Adoption of Hypofractionation for Early-Stage Breast Cancer.
Chapman BV; Rajagopalan MS; Heron DE; Flickinger JC; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):854-61. PubMed ID: 26530754
[TBL] [Abstract][Full Text] [Related]
8. The Pattern of Use of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer in New South Wales, Australia, 2008 to 2012.
Delaney GP; Gandhidasan S; Walton R; Terlich F; Baker D; Currow D
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):266-272. PubMed ID: 27473814
[TBL] [Abstract][Full Text] [Related]
9. The impact of hypofractionated whole breast radiotherapy on local relapse in patients with Grade 3 early breast cancer: a population-based cohort study.
Herbert C; Nichol A; Olivotto I; Weir L; Woods R; Speers C; Truong P; Tyldesley S
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2086-92. PubMed ID: 21477936
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer.
Boero IJ; Gillespie EF; Hou J; Paravati AJ; Kim E; Einck JP; Yashar C; Mell LK; Murphy JD
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):571-580. PubMed ID: 28126306
[TBL] [Abstract][Full Text] [Related]
11. Distance to Radiation Facility and Treatment Choice in Early-Stage Breast Cancer.
Acharya S; Hsieh S; Michalski JM; Shinohara ET; Perkins SM
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):691-9. PubMed ID: 26972641
[TBL] [Abstract][Full Text] [Related]
12. Utilization trend and regimens of hypofractionated whole breast radiation therapy in the United States.
Hasan Y; Waller J; Yao K; Chmura SJ; Huo D
Breast Cancer Res Treat; 2017 Apr; 162(2):317-328. PubMed ID: 28120272
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with radiation therapy incompletion for patients with early-stage breast cancer.
Freedman RA; Fedewa SA; Punglia RS; Lin CC; Ward EM; Jemal A; Sineshaw HM
Breast Cancer Res Treat; 2016 Jan; 155(1):187-99. PubMed ID: 26683609
[TBL] [Abstract][Full Text] [Related]
14. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.
Gill BS; Lin JF; Krivak TC; Sukumvanich P; Laskey RA; Ross MS; Lesnock JL; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1083-90. PubMed ID: 25216857
[TBL] [Abstract][Full Text] [Related]
15. Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women.
Punglia RS; Weeks JC; Neville BA; Earle CC
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):56-63. PubMed ID: 16814955
[TBL] [Abstract][Full Text] [Related]
16. Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis.
Venigalla S; Guttmann DM; Jain V; Sharma S; Freedman GM; Shabason JE
Clin Breast Cancer; 2018 Oct; 18(5):e899-e908. PubMed ID: 29550285
[TBL] [Abstract][Full Text] [Related]
17. Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart.
Appelt AL; Vogelius IR; Bentzen SM
Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):147-52. PubMed ID: 22910644
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.
Lalani N; Paszat L; Sutradhar R; Thiruchelvam D; Nofech-Mozes S; Hanna W; Slodkowska E; Done SJ; Miller N; Youngson B; Tuck A; Sengupta S; Elavathil L; Chang MC; Jani PA; Bonin M; Rakovitch E
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1017-24. PubMed ID: 25220719
[TBL] [Abstract][Full Text] [Related]
19. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
